Psychedelic drugs will follow pot’s path to legalisation
If psychedelics can be shown to work in controlled scientific studies, that will create a powerful argument for their legal, medical use
17 May 2021 - 05:05
Cambridge — Here come the psychedelics. A striking new study published in Nature Medicine argues that MDMA-assisted psychotherapy represents “a potential breakthrough treatment” for post-traumatic stress disorder.
Other studies are in the works considering the potential therapeutic applications of psilocybin (the active ingredient in magic mushrooms), LSD and cannabinoids. These follow well-received books on different forms of psychedelic use by such mainstream figures as food writer Michael Pollan, novelist Ayelet Waldman and columnist Ezra Klein...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.